218 related articles for article (PubMed ID: 33688489)
1. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy.
De B; Ng SP; Liu AY; Avila S; Tao R; Holliday EB; Brownlee Z; Kaseb A; Lee S; Raghav K; Vauthey JN; Minsky BD; Herman JM; Das P; Smith GL; Taniguchi CM; Krishnan S; Crane CH; Grassberger C; Hong TS; Lin SH; Koong AC; Mohan R; Koay EJ
J Hepatocell Carcinoma; 2021; 8():57-69. PubMed ID: 33688489
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
Lee G; Kim DW; Smart AC; Horick NK; Eyler CE; Roberts HJ; Pathak P; Goyal L; Franses J; Heather JM; Hwang WL; Grassberger C; Klempner SJ; Drapek LC; Allen JN; Blaszkowsky LS; Parikh AR; Ryan DP; Clark JW; Hong TS; Wo JY
Am J Clin Oncol; 2024 May; ():. PubMed ID: 38767086
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of absolute lymphocyte count in patients with advanced esophageal cancer treated with immunotherapy: a retrospective analysis.
Zhao Q; Bi Y; Xue J; Liu Y; Zhu J; Qin S
Ann Transl Med; 2022 Jul; 10(13):744. PubMed ID: 35957729
[TBL] [Abstract][Full Text] [Related]
5. Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients.
Wang X; Zhao Z; Wang P; Geng X; Zhu L; Li M
Front Oncol; 2020; 10():997. PubMed ID: 32656085
[No Abstract] [Full Text] [Related]
6. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
[TBL] [Abstract][Full Text] [Related]
7. Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma.
Liu J; Zhao Q; Deng W; Lu J; Xu X; Wang R; Li X; Yue J
Radiat Oncol; 2017 May; 12(1):90. PubMed ID: 28558844
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
9. A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer.
Xu Z; Yang L; Yu H; Guo L
Front Oncol; 2022; 12():905222. PubMed ID: 36185193
[TBL] [Abstract][Full Text] [Related]
10. Proton and Carbon Ion Radiation Therapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Doses in Non-Small Cell Lung Cancer Versus Intensity Modulated Radiation Therapy.
Li Y; Fan X; Yu Q; Zhai H; Mo M; Sun J; Mi J; Lu R; Mao J; Chen J; Ma N; Yang W; Zhu J; Jiang G; Wu K
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):579-589. PubMed ID: 36586495
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.
Hsieh RC; Lee CH; Huang HC; Wu SW; Chou CY; Hung SP; Lee CW; Krishnan S; Venkatesulu BP; Lee JC; Chou YC; Chan KM; Lin PT; Lee WC; Lin CC; Lin SY; Hong JH
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):712-724. PubMed ID: 37778426
[TBL] [Abstract][Full Text] [Related]
12. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
Mohan R; Liu AY; Brown PD; Mahajan A; Dinh J; Chung C; McAvoy S; McAleer MF; Lin SH; Li J; Ghia AJ; Zhu C; Sulman EP; de Groot JF; Heimberger AB; McGovern SL; Grassberger C; Shih H; Ellsworth S; Grosshans DR
Neuro Oncol; 2021 Feb; 23(2):284-294. PubMed ID: 32750703
[TBL] [Abstract][Full Text] [Related]
13. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
[TBL] [Abstract][Full Text] [Related]
14. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Cortez MA; Welsh JW
Radiother Oncol; 2020 Sep; 150():114-120. PubMed ID: 32525003
[TBL] [Abstract][Full Text] [Related]
15. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes.
Wang X; Lu J; Teng F; Yu J
Ann Transl Med; 2019 Aug; 7(16):385. PubMed ID: 31555699
[TBL] [Abstract][Full Text] [Related]
17. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
[TBL] [Abstract][Full Text] [Related]
18. Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma.
Zhao Q; Xu X; Yue J; Zhu K; Feng R; Jiang S; Qi Z; Wang R
Therap Adv Gastroenterol; 2017 Feb; 10(2):231-241. PubMed ID: 28203281
[TBL] [Abstract][Full Text] [Related]
19. Lymphopenia Is Associated with Gross Target Volumes and Fractions in Hepatocellular Carcinoma Patients Treated with External Beam Radiation Therapy and Also Indicates Worse Overall Survival.
Zhang HG; Yang P; Jiang T; Zhang JY; Jin XJ; Hu Y; Sun J; Du SS; Zeng ZC
Can J Gastroenterol Hepatol; 2019; 2019():9691067. PubMed ID: 31781521
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy.
Liu M; Li X; Cheng H; Wang Y; Tian Y
Cancer Manag Res; 2021; 13():2917-2924. PubMed ID: 33833575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
